
Professor Alfredo Iacoangeli
Professor of Bioinformatics and Artificial Intelligence for Genomic Medicine
Contact details
Pronouns
he/him
Biography
After a career in Biophysics, Professor Alfredo Iacoangeli accepted his PhD "cum laude" in Life Sciences in 2016 from Sapienza University of Rome where he worked in the field of structural bioinformatics with a particular focus on protein structure prediction and protein-peptide interaction.
Alfredo joined King’s College London in March 2016, and is now the lead of a joint programme between the Department of Basic & Clinical Neuroscience and the Department of Biostatistics & Health Informatics at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London.
The aim of this programme is two-fold:
1) The development of computational approaches based on statistical, machine learning and bioinformatics methods, to study the biological basis of neurodegenerative diseases;
2) Exploiting large multi-omics and clinical datasets using AI and statistical methods to identify develop personalised medicine solutions for neurodegenerative diseases.
Research interests
- Bioinformatics
- Machine learning
- Genomics
- Personalised medicine
- Motor Neurone Disease
- Neurodegeneration
Teaching
MSc modules:
- Bioinformatics, interpretation and data quality assurance in genome analysis
- Advanced Bioinformatics
Centres for Doctoral Training courses:
- Next-Generation Sequencing Data: DNA Sequencing
- Next-Generation Sequencing Data: RNA Sequencing
Expertise and public engagement
- Winner of the “ENCALS 2021 award”
- Winner of the “Genes 2022 Young Investigator Award in Human Genomics and Genetic Diseases”
- Winner of the Paulo Gontijo Award 2024
- NIHR Maudsley BRC MND Theme Deputy Lead
- Former Project MinE Data Infrastructure working group Chair
- NIHR BioResource Centre Maudsley Rare Diseases lead
- Darby-Rimmer MND Foundation scientific advisory panel
- 2023 ALS Canada-Brain Canada Trainee Award review panel member
News
Dr Alfredo Iacoangeli receives the 2024 Paolo Gontijo Award
Dr Alfredo Iacoangeli was awarded the Paulo Gontijo award at the 35th International Symposium on ALS/MND on 6 December 2024 in Montreal, Canada.

King's researcher receives nearly £1 million to investigate the role of ancient viral DNA in ALS
Dr Alfredo Iacoangeli has been awarded £983,708 funding from the Medical Research Council (MRC) to explore how genetic sequences acquired millions of years...

Over £1.4 million awarded to King's researchers to accelerate MND treatment development
Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

Over £1.4 million awarded to King's researchers to accelerate MND treatment development
Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

King's Motor Neurone Disease Care and Research Centre Hosts Delegation from Perron Institute and Western Australian Government
The esteemed guests included Steve Arnott, CEO of Perron Institute, and John Langoulant, Agent General for Western Australia.

King's College London and LifeArc team up to accelerate MND treatment development
LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London.

Dr Alfredo Iacoangeli receives Genes 2022 Young Investigator Award in Human Genomics and Genetic Diseases
Dr Alfredo Iacoangeli was recognised by the journal, Genes, for his contributions to the fields of human genomics and genetic diseases.

News
Dr Alfredo Iacoangeli receives the 2024 Paolo Gontijo Award
Dr Alfredo Iacoangeli was awarded the Paulo Gontijo award at the 35th International Symposium on ALS/MND on 6 December 2024 in Montreal, Canada.

King's researcher receives nearly £1 million to investigate the role of ancient viral DNA in ALS
Dr Alfredo Iacoangeli has been awarded £983,708 funding from the Medical Research Council (MRC) to explore how genetic sequences acquired millions of years...

Over £1.4 million awarded to King's researchers to accelerate MND treatment development
Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

Over £1.4 million awarded to King's researchers to accelerate MND treatment development
Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

King's Motor Neurone Disease Care and Research Centre Hosts Delegation from Perron Institute and Western Australian Government
The esteemed guests included Steve Arnott, CEO of Perron Institute, and John Langoulant, Agent General for Western Australia.

King's College London and LifeArc team up to accelerate MND treatment development
LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London.

Dr Alfredo Iacoangeli receives Genes 2022 Young Investigator Award in Human Genomics and Genetic Diseases
Dr Alfredo Iacoangeli was recognised by the journal, Genes, for his contributions to the fields of human genomics and genetic diseases.
